| 000 | 01576 a2200457 4500 | ||
|---|---|---|---|
| 005 | 20250512022933.0 | ||
| 264 | 0 | _c19860121 | |
| 008 | 198601s 0 0 eng d | ||
| 022 | _a0312-5963 | ||
| 024 | 7 |
_a10.2165/00003088-198510060-00002 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aPaton, D M | |
| 245 | 0 | 0 |
_aClinical pharmacokinetics of H1-receptor antagonists (the antihistamines). _h[electronic resource] |
| 260 |
_bClinical pharmacokinetics _c |
||
| 300 |
_a477-97 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't; Review | ||
| 650 | 0 | 4 | _aAstemizole |
| 650 | 0 | 4 |
_aBenzhydryl Compounds _xmetabolism |
| 650 | 0 | 4 |
_aBenzimidazoles _xmetabolism |
| 650 | 0 | 4 |
_aBrompheniramine _xmetabolism |
| 650 | 0 | 4 | _aChromatography, Gas |
| 650 | 0 | 4 | _aChromatography, High Pressure Liquid |
| 650 | 0 | 4 |
_aCyproheptadine _xmetabolism |
| 650 | 0 | 4 |
_aDiphenhydramine _xmetabolism |
| 650 | 0 | 4 | _aEthnicity |
| 650 | 0 | 4 | _aHalf-Life |
| 650 | 0 | 4 |
_aHistamine H1 Antagonists _xblood |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aIntestinal Absorption |
| 650 | 0 | 4 |
_aKidney Diseases _xmetabolism |
| 650 | 0 | 4 | _aKinetics |
| 650 | 0 | 4 |
_aLiver Diseases _xmetabolism |
| 650 | 0 | 4 |
_aPiperazines _xmetabolism |
| 650 | 0 | 4 |
_aPromethazine _xmetabolism |
| 650 | 0 | 4 | _aProtein Binding |
| 650 | 0 | 4 | _aTerfenadine |
| 650 | 0 | 4 | _aTissue Distribution |
| 700 | 1 | _aWebster, D R | |
| 773 | 0 |
_tClinical pharmacokinetics _gvol. 10 _gno. 6 _gp. 477-97 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.2165/00003088-198510060-00002 _zAvailable from publisher's website |
| 999 |
_c2871916 _d2871916 |
||